causal

Single-target therapies leave most tumor cells alive

Highly mutated tumors such as glioblastoma contain hundreds of mutations, so a targeted therapy that kills the subset carrying one mutation (illustrated as 20 percent) leaves the rest, which then grow, making most tumors not one target away from eradication.

causalpending

Speaker

Bill

Evidence Quote

“Let's say 20% of the cancer cells have that mutation that can be targeted. You kill those 20%, but then the 80% come in and they grow”

Source

Novocure: Using Physics to Fight Cancer— Business Breakdowns
Created: 11/19/2026, 2:27:17 AM

Your notes

Loading notes...